KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Short term Debt (2016 - 2025)

Merck (MRK) has disclosed Short term Debt for 17 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 2.27% to $2.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Dec 2025, down 2.27% year-over-year, with the annual reading at $2.6 billion for FY2025, 2.27% down from the prior year.
  • Short term Debt for Q4 2025 was $2.6 billion at Merck, up from $1.4 billion in the prior quarter.
  • The five-year high for Short term Debt was $7.3 billion in Q1 2021, with the low at $887.0 million in Q3 2023.
  • Average Short term Debt over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2021.
  • The sharpest move saw Short term Debt crashed 83.34% in 2022, then surged 255.02% in 2024.
  • Over 5 years, Short term Debt stood at $2.4 billion in 2021, then fell by 19.32% to $1.9 billion in 2022, then dropped by 29.5% to $1.4 billion in 2023, then skyrocketed by 93.08% to $2.6 billion in 2024, then decreased by 2.27% to $2.6 billion in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $2.6 billion, $1.4 billion, and $1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.